Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.dishmangroup.com | |
Market Cap | 3,666.37 Cr. | |
Enterprise Value(EV) | 5,219.97 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -9.84 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.22 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 364.27 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.64 | Calculated using Price: 233.85 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 15.68 Cr. | 156,783,095 Shares |
FaceValue | 2 | |
About Dishman Carbogen Amcis Ltd. | ||
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies. |
1 Day |
|
+0.73% |
1 Week |
|
+2.62% |
1 Month |
|
+3.71% |
3 Month |
|
+22.61% |
6 Month |
|
+59.73% |
1 Year |
|
+74.41% |
2 Year |
|
+28.09% |
5 Year |
|
+4.31% |
10 Year |
|
7 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3654.02 | 6.05 | 4.01 | 2.86 | -2.89 | 0.32 | -0.52 | |
Return on Capital Employed (%) | 4.6 | 4.67 | 5.79 | 3.93 | -0.26 | 0.76 | 0.43 | |
Return on Assets (%) | 2.21 | 2.25 | 2.9 | 2.04 | -2 | 0.21 | -0.33 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4,814 | 5,107 | 5,379 | 5,715 | 5,699 | 5,549 | 5,810 | 5,771 | |
Non Curr. Liab. | 767 | 884 | 743 | 909 | 1,367 | 1,665 | 1,831 | 1,840 | |
Curr. Liab. | 994 | 1,178 | 1,198 | 1,569 | 1,290 | 1,420 | 1,798 | 1,882 | |
Minority Int. | |||||||||
Equity & Liab. | 6,574 | 7,169 | 7,321 | 8,193 | 8,356 | 8,634 | 9,439 | 9,493 | |
Non Curr. Assets | 5,241 | 5,623 | 5,767 | 6,414 | 6,652 | 6,795 | 7,521 | 7,530 | |
Curr. Assets | 1,333 | 1,546 | 1,554 | 1,779 | 1,704 | 1,839 | 1,918 | 1,963 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 6,574 | 7,169 | 7,321 | 8,193 | 8,356 | 8,634 | 9,439 | 9,493 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 1,714 | 1,695 | 2,059 | 2,044 | 1,912 | 2,141 | 2,413 | 2,580 | |
Other Income | 26 | 53 | 54 | 44 | 39 | 49 | 28 | 28 | |
Total Income | 1,740 | 1,748 | 2,112 | 2,088 | 1,951 | 2,190 | 2,441 | 2,607 | |
Total Expenditure | -1,260 | -1,257 | -1,507 | -1,546 | -1,638 | -1,815 | -2,081 | -2,304 | |
PBIDT | 479 | 491 | 606 | 542 | 313 | 375 | 360 | 303 | |
Interest | -49 | -49 | -57 | -62 | -48 | -57 | -86 | -113 | |
Depreciation | -214 | -211 | -240 | -283 | -308 | -308 | -281 | -302 | |
Taxation | -71 | -76 | -98 | -39 | -100 | 22 | 25 | 6 | |
Exceptional Items | -22 | -15 | -48 | -49 | |||||
PAT | 145 | 155 | 210 | 159 | -165 | 18 | -30 | -154 | |
Minority Interest | |||||||||
Share Associate | |||||||||
Other Related Items | 15 | ||||||||
Consolidated Net Profit | 161 | 155 | 210 | 159 | -165 | 18 | -30 | -154 | |
Adjusted EPS | 10 | 13 | 10 | -11 | 1 | -2 | -10 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 303 | 226 | 282 | 585 | 513 | 355 | 220 | |
Cash Fr. Inv. | -142 | -297 | -169 | -442 | -380 | -619 | -448 | |
Cash Fr. Finan. | -137 | 78 | -102 | -98 | -11 | 130 | 250 | |
Net Change | 23 | 7 | 11 | 46 | 122 | -133 | 22 | |
Cash & Cash Eqvt | 59 | 66 | 76 | 122 | 244 | 110 | 132 |
Thu, 11 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Dishman Carbogen Amcis Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Mon, 01 Apr 2024
Cessation Dishman Carbogen Amcis Limited has informed the Exchange regarding Cessation of Mr Ashok C. Gandhi as Non- Executive Independent Director of the company w.e.f. April 01, 2024. |
Mon, 01 Apr 2024
Cessation Dishman Carbogen Amcis Limited has informed the Exchange regarding Cessation of Mr Sanjay S. Majmudar as Non- Executive Independent Director of the company w.e.f. April 01, 2024. |
Wed, 24 Apr 2024 |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |
Closing Near 20 SMA |
Tue, 23 Apr 2024 |
Higher Delivery Quantity |